openPR Logo
Press release

Rise in Prevalence of COPD and Asthma anticipated to Drive Global Smart Inhalers Market: Ken Research

09-28-2021 01:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Ken Research Pvt Ltd

Rise in Prevalence of COPD and Asthma anticipated to Drive Global

A smart inhaler is also recognized as connected inhaler and sensors. Smart inhalers are specific devices, used to deliver various medications through the inhalation. Some drugs used in the inhalers include glucocorticoids, insulin, anti-cholinergic, and beta-agonists for treatment & prevention of the respiratory diseases for instance asthma and chronic obstructive pulmonary diseases (COPD). The data captured by these smart inhalers is shared with the patients & healthcare professionals to track their usage. The monitored data is then shared using Bluetooth technology for their mobile applications through a platform like Hailie. A Hailie system is a special type of sensor that connects to the inhaler and shares data on the control platform to monitor the health and compliance rate.

As per analysis, “Smart Inhalers Market: Current Analysis and Forecast (2021-2028)” the key companies operating in the global smart inhalers market include Teva Pharmaceuticals Industries Ltd., Cohero Health Inc., Boehringer Ingelheim, Vectura Group, Adherium Limited, Novartis, Omron Corp., 3M, Glaxosmithkline, Astrazeneca and among others. Well-known manufacturers focus on partnering with digital & software players to serve the target audience. In addition, these partnerships also facilitate the manufacturers launch their products more profitably as well as improve their distribution channels.

For More Information, refer to below link:-

By product type, smart inhalers market is bifurcated as nebulizers and inhalers (Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI)). Inhalers segment dominates the global market owing to regular use of inhalers that enables the caregivers, patients, and doctors to keep the track of patient's dosage & usage of inhalers. By indication, market is bifurcated as asthma and Chronic Obstructive Pulmonary Disease (COPD). Also in terms of distribution channel, the market can be categorized into retail pharmacies, hospital pharmacies, and online channel. Hospital pharmacies segment is predicted to witness higher growth rate due to easy availability of smart inhalers at hospital pharmacies during the forecast period.

Growth in adoption of smart inhalers for proper management of COPD & asthma, followed by rise in levels of pollution and increase in acceptance towards digital healthcare equipment are some major factors, which are responsible for growth of the smart inhalers market. However, high cost of asthma and COPD treatment and misusing data & data privacy may impact the market. Moreover, increase in research & development (R&D) activities, growth in focus towards advanced treatment protocols and increase in modernization & technological advancements in the healthcare sector are leading opportunities for market.

Based on regional analysis, the North-America is a leading region in global smart inhalers market owing to increase in prevalence of COPD & asthma, rise in per capita income and growth in population susceptible to indoor air pollutants across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to growth in number of product development coupled with growth in healthcare expenditure over the forecast period. It is predicted that future of the global market will be bright as a result of rise in prevalence of respiratory diseases coupled with increase in collaboration between pharma and digital health companies during the forecast period.

For More Information, refer to below link:-

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a research based management consulting company. We provide strategic consultancy to aid clients on critical business perspective: strategy, marketing, organization, operations and technology transformation, advanced analytics, corporate finance, mergers & acquisitions and sustainability across all industries and geographies. We provide business intelligence and operational advisory across 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Some of top consulting companies and Market leaders seek our intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

We currently cater to 300+ sectors with 150,000+ research repository across 196+ countries serving 1000+ clients and have partnered with almost 25+ content aggregators.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Prevalence of COPD and Asthma anticipated to Drive Global Smart Inhalers Market: Ken Research here

News-ID: 2409930 • Views: 268

More Releases from Ken Research Pvt Ltd

Global Sponge Rubber Materials Market Size and Research 2021, CAGR Status, Growt …
Sponge rubber can be designed to be open cell or closed cell, but is most primarily utilized as closed cell and is also well-known as enlarged rubber. Inside a piece of sponge rubber, there are attached capsules, or cells, that do not link with each other. They look very same to the “bubbles” in piece of exceptionally dense foam. In addition, the sponge rubber can be laminated with the adhesive,
Global Specialty Zeolites Market, Global Specialty Zeolites Industry, Covid-19 I …
The Specialty Zeolites market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Specialty Zeolites Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Specialty Zeolites market. The report focuses on well-known providers in the global
Global Cruising Sailboats Market, Global Cruising Sailboats Industry, Covid-19 I …
The Cruising Sailboats market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Cruising Sailboats Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Cruising Sailboats market. The report focuses on well-known providers in the global
UAE Online Loan Aggregator Market Size and Research 2021, CAGR Status, Growth An …
Introduction Loan aggregator is a middleman organization that gathers an individual personal and financial information on a loan applications and shops it around who might propose an individual a loan. Such aggregators charge some amount of price to deliver the individual end-to-end service in their entire loan application procedure. The online loan aggregator is speedily being accepted around underdeveloped region, for instance, around UAE, the online loan aggregator has emerged as

All 5 Releases

More Releases for COPD

COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the